Prosperia, the artificial intelligence system that prevents diabetic blindness in Mexico

Prosperia is a technology solutions company based on AI, created to massify the early detection of chronic diseases, is currently implementing this system in Mexico, helping the detection and timely treatment of diabetes and hypertension, as well as its ophthalmological complications, including diabetic retinopathy.
This disease is the leading cause of irreversible blindness in productive age, unfortunately in Mexico less than 20% of cases are diagnosed, which means costly treatments for the patient and without the probability of maintaining their vision.
Prosperia's system uses a risk calculator, based on questionnaires, supported by models trained with data from the Mexican population, which allows to identify patients who may suffer from diabetes or hypertension, in addition to calculating the probability of developing complications of these diseases that affect the patient's vision.
Moreover, the system is capable of evaluating retinal photographs taken of the patient, automatically by means of AI, and determining the lesions that may be present in the eye.
The company estimates that a timely diagnosis would reduce an annual expenditure of more than 3 billion pesos. Mexico is the sixth country in the world with diabetes, being this disease the second cause of mortality, equivalent to approximately 100,000 people a year, according to data issued by the National Institute of Statistics and Geography (INEGI).
Prosperia has stated that they not only work in cases of diabetic retinopathy, they also deal with cases of other ophthalmologic pathologies, cardiovascular diseases and oncology.
The health sector, regardless of the country, has benefited from the technology offered by artificial intelligence systems, allowing them to diagnose pathologies in time, which not only saves the patient's life, but also saves billions of dollars in annual medical expenses.
You can access its risk calculator, free of charge, on the official website https://es.prosperia.health/


